Cargando…

Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium

The aldehyde dehydrogenase 2 (ALDH2) polymorphism rs671 (Glu504Lys) causes ALDH2 inactivation and adverse acetaldehyde exposure among Asians, but little is known of the association between alcohol consumption and rs671 and ovarian cancer (OvCa) in Asians. We conducted a pooled analysis of Asian ance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ugai, Tomotaka, Kelemen, Linda E., Mizuno, Mika, Ong, Jue‐Sheng, Webb, Penelope M., Chenevix‐Trench, Georgia, Wicklund, Kristine G., Doherty, Jennifer Anne, Rossing, Mary Anne, Thompson, Pamela J., Wilkens, Lynne R., Carney, Michael E., Goodman, Marc T., Schildkraut, Joellen M., Berchuck, Andrew, Cramer, Daniel W., Terry, Kathryn L., Cai, Hui, Shu, Xiao‐Ou, Gao, Yu‐Tang, Xiang, Yong‐Bing, Van Den Berg, David, Pike, Malcom C, Wu, Anna H., Pearce, Celeste Leigh, Matsuo, Keitaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797830/ https://www.ncbi.nlm.nih.gov/pubmed/29247577 http://dx.doi.org/10.1111/cas.13470

Ejemplares similares

Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium
por: Lurie, Galina, et al.
Publicado: (2011)

Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
por: Dixon, Suzanne C, et al.
Publicado: (2017)

Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium
por: Cannioto, Rikki A, et al.
Publicado: (2016)

Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium
por: Kelemen, Linda E, et al.
Publicado: (2013)

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium
por: Pearce, C L, et al.
Publicado: (2009)

Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium
por: Pearce, C L, et al.
Publicado: (2009)

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
por: Pearce, C L, et al.
Publicado: (2008)

History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report
por: Minlikeeva, Albina N, et al.
Publicado: (2017)

Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium
por: Amankwah, Ernest K., et al.
Publicado: (2011)

Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
por: Nagle, C M, et al.
Publicado: (2015)

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
por: Köbel, Martin, et al.
Publicado: (2023)

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
por: Rambau, Peter F, et al.
Publicado: (2018)

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
por: Pearce, Celeste Leigh, et al.
Publicado: (2012)

Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer
por: Schildkraut, Joellen M., et al.
Publicado: (2010)

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas
por: Arnold, J M, et al.
Publicado: (2001)

Aldehydes, Aldehyde Metabolism, and the ALDH2 Consortium
por: Rwere, Freeborn, et al.
Publicado: (2022)

Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
por: Kelemen, Linda E., et al.
Publicado: (2012)

Primary peritoneal and ovarian cancers: an epidemiological comparative analysis
por: Grant, Delores J., et al.
Publicado: (2010)

Reply to ‘Comment on ‘Dairy, calcium, vitamin D and ovarian cancer risk in African–American women’’
por: Qin, Bo, et al.
Publicado: (2018)

Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas
por: Arnold, J M, et al.
Publicado: (2001)

Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility
por: Hurwitz, Lauren M., et al.
Publicado: (2023)

CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
por: Kang, Eun‐Young, et al.
Publicado: (2022)

ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers
por: Chang, Bin, et al.
Publicado: (2009)

The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium
por: Ugai, Tomotaka, et al.
Publicado: (2019)

Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.
por: Lancaster, J. M., et al.
Publicado: (1998)

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
por: Weir, Ashley, et al.
Publicado: (2022)

Effects of risk factors for ovarian cancer in women with and without endometriosis
por: Phung, Minh Tung, et al.
Publicado: (2022)

Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer
por: Lai, J, et al.
Publicado: (2003)

Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”
por: Johnatty, Sharon E., et al.
Publicado: (2010)

The Australian Ovarian Cancer Study
por: Traficante, N, et al.
Publicado: (2012)

The importance of using public data to validate reported associations
por: Chenevix-Trench, Georgia, et al.
Publicado: (2018)

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
por: Arnold, J M, et al.
Publicado: (2005)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

A targeted genetic association study of epithelial ovarian cancer susceptibility
por: Earp, Madalene, et al.
Publicado: (2016)

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
por: White, Kristin L, et al.
Publicado: (2009)

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
por: Park, Young Tae, et al.
Publicado: (2013)

Correlation of ALDH1 and Notch3 Expression: Clinical implication in Ovarian Carcinomas
por: Kim, Mi Joung, et al.
Publicado: (2017)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
por: Wohlmuth, Christoph, et al.
Publicado: (2022)

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
por: Martins, Filipe Correia, et al.
Publicado: (2020)

Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
por: Gersekowski, Kate, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_felqrqfq555u3c7g5v7mr2b181